Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 11/20 | 0.57 |
| ▸ | MEN1 | O00255 | 10/20 | 0.57 |
| ▸ | MAPT | P10636 | 8/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | MET | P08581 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | PDE9A | O76083 | 1/20 | 0.48 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | MITF | O75030 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11523970 | 0.82 | KMT2A (0.66) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL14410372 | 0.80 | MAPT (0.67) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL9816832 | 0.80 | KMT2A (0.66) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL25414323 | 0.79 | KMT2A (0.53) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL26315649 | 0.79 | KMT2A (0.53) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL16355193 | 0.78 | MAPT (0.52) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL10184550 | 0.77 | MAPT (0.65) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL15137876 | 0.76 | KMT2A (0.61) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL13415624 | 0.76 | MET (0.53) | KMT2AMEN1MAPTALDH1A1MET | |
| SCHEMBL14132237 | 0.76 | MAPT (0.52) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975102-B1 | Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents | KING ABDULAZIZ UNIVERSITY (SA) | 2021-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975102-B1 | Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents | PDXK, IDH1, SOD1 | KMT2A 2435/4885MEN1 446/4885MAPT 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.